© 2025 Myocardial Solutions Inc. All rights reserved.
MORRISVILLE, N.C., April 25, 2019 – A clinical review article that describes the history and evolution of MyoStrain® was published in the ESC Heart Failure journal. The Manuscript, titled: “Strain‐encoded magnetic resonance: a method for the assessment of myocardial deformation”, summarizes the existing literature on the MyoStrain technology and its predecessor technologies, which totals over 250 prior articles. The technology has evolved and improved from HARP to SENC to, now, fast-SENC (MyoStrain).
More detail of the manuscript is listed below:
Title: Strain-encoded Magnetic Resonance: A Method for the Assessment of Myocardial Deformation
Citation: Korosoglou G, et al. Strain-encoded Magnetic Resonance: A Method for the Assessment of Myocardial Deformation. ESC Heart Failure. 2019:1-19. doi:10.1002/ehf2.12442.
PR@myocardialsolutions.com
919.677.8100
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.
